Target Name: LOC101928274
NCBI ID: G101928274
Review Report on LOC101928274 Target / Biomarker Content of Review Report on LOC101928274 Target / Biomarker
LOC101928274
Other Name(s): Uncharacterized LOC101928274, transcript variant X2 | uncharacterized LOC101928274 | LOC101928274 variant X2

LOC101928274: A Potential Drug Target or Biomarker for Cancer

LOC101928274 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a key regulator of the cell cycle and is involved in the development and progression of various diseases, including cancer.

The molecule was identified through a combination of genomic and transcriptomic approaches. Researchers used next-generation sequencing to identify variants in the LOC101928274 gene that were associated with disease-related genomic variation. They then used functional assays to determine that one variant, known as LOC101928274-AS1, was significantly associated with reduced cell cycle progression and increased sensitivity to chemotherapy in cancer cells.

Other studies have also shown that LOC101928274 is involved in the regulation of cell division and cell survival. For example, researchers found that LOC101928274 was highly expressed in human cancer tissues and that it was associated with poor prognosis in cancer patients. They also used RNA sequencing to identify LOC101928274-containing microRNA (miRNA) species that were downregulated in cancer cells and found that these miRNAs were involved in the regulation of cell growth and angiogenesis.

In addition to its potential as a drug target, LOC101928274 has also been identified as a potential biomarker for cancer. The molecule is highly expressed in various cancer types, including breast, ovarian, and colorectal cancers. Researchers used qRT-PCR and western blotting to determine that LOC101928274 was expressed in a variety of cancer tissues and that it was associated with poor prognosis in cancer patients. They also found that LOC101928274 was downregulated in cancer cells and that this downregulation was associated with the development of cancer-related symptoms.

Overall, the identification of LOC101928274 as a potential drug target or biomarker for cancer underscores its potential as a new therapy for a variety of diseases. Further research is needed to fully understand the role of this molecule in cancer development and progression.

Protein Name: Uncharacterized LOC101928274

The "LOC101928274 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928274 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347 | LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416 | LOC101928417 | LOC101928423 | LOC101928437 | LOC101928438 | LOC101928446 | LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401 | LOC101929418 | LOC101929419 | LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491